Position in ACRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$757,612
+$474,859 QoQ
Shares Held
143,216
+89.9% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 149 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ACRS ranks #156 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ACRS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $757,612 | 143,216 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $282,753 | 75,401 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $216,130 | 71,804 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $173,348 | 91,236 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $120,650 | 84,965 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $46,205 | 42,005 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $120,552 | 97,220 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $100,537 | 95,750 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $701,672 | 102,434 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,081,870 | 104,327 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $709,946 | 87,756 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,352,326 | 85,862 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,314,164 | 83,492 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,005,106 | 71,999 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $951,544 | 55,194 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $679,381 | 46,725 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $815,418 | 45,301 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $735,166 | 41,866 | Shares | Sole | 2021-08-05 | |
| 2020-03-31 | $53,691 | 51,626 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||